BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 16411390)

  • 1. Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VII.
    Schulman S; Tjønnfjord GE; Wallensten R; Martinowitz U; Kenet G
    Thromb Haemost; 2005 Dec; 94(6):1177-80. PubMed ID: 16411390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
    Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
    Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII: plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleeding.
    Smith MP; Ludlam CA; Collins PW; Hay CR; Wilde JT; Grigeri A; Melsen T; Savidge GF
    Thromb Haemost; 2001 Oct; 86(4):949-53. PubMed ID: 11686351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. rFVIIa administered by continuous infusion during surgery in patients with severe congenital FVII deficiency.
    Tran HT; Tjønnfjord GE; Paus A; Holme PA
    Haemophilia; 2011 Sep; 17(5):764-70. PubMed ID: 21707871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of using recombinant factor VIIa in continuous infusion.
    Schulman S; Bech Jensen M; Varon D; Keller N; Gitel S; Horoszowski H; Heim M; Martinowitz U
    Thromb Haemost; 1996 Mar; 75(3):432-6. PubMed ID: 8701403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Continuous infusion of recombinant activated factor VII during and after elbow arthroplasty in a hemophilia A patient with inhibitors].
    Nakamura M; Terashima K; Takashima Y; Amano K; Horikoshi Y; Mimaya J
    Rinsho Ketsueki; 2002 Mar; 43(3):183-8. PubMed ID: 11979750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency.
    Huang WY; Kruskall MS; Bauer KA; Uhl L; Shaz BH
    Transfusion; 2004 Nov; 44(11):1562-6. PubMed ID: 15504160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
    Brandsborg S; Sørensen B; Poulsen LH; Ingerslev J
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between recombinant activated factor VII (Aryoseven) and Novoseven in patients with congenital factor VII deficiency.
    Faranoush M; Abolghasemi H; Toogeh G; Karimi M; Eshghi P; Managhchi M; Hoorfar H; Dehdezi BK; Mehrvar A; Khoeiny B; Kamyar K; Heshmat R; Baghaeipour MR; Mirbehbahani NB; Fayazfar R; Ahmadinejad M; Naderi M
    Clin Appl Thromb Hemost; 2015 Nov; 21(8):724-8. PubMed ID: 24651301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of recombinant activated factor VII administered by continuous infusion to inhibitor patients undergoing elective major orthopaedic surgery: a pharmacokinetic and efficacy evaluation.
    Ludlam CA; Smith MP; Morfini M; Gringeri A; Santagostino E; Savidge GF
    Br J Haematol; 2003 Mar; 120(5):808-13. PubMed ID: 12614214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of recombinant activated factor VII in the circumcision operation in the case of a congenital factor VII deficiency.
    Canatan D; Eren E; Ozgüner IF; Duman H; Eren C; Büyükyavuz I; Savaş C
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):375-6. PubMed ID: 17473581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
    Brenner B; Wiis J
    Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased volume of distribution for recombinant activated factor VII and longer plasma-derived factor VII half-life may explain their long lasting prophylactic effect.
    Mathijssen NC; Masereeuw R; Holme PA; van Kraaij MG; Laros-van Gorkom BA; Peyvandi F; van Heerde WL
    Thromb Res; 2013 Aug; 132(2):256-62. PubMed ID: 23834817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenicity of activated recombinant factor VII followed through nine years of clinical experience.
    Nicolaisen EM
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S119-23. PubMed ID: 9819042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical assessment of potential fields of application of recombinant factor VIIa in internal and pediatric diseases. Recommendations of an expert group].
    Dempfle CE; Gulba D; Kirchmaier CM; Klamroth R; Korte W; Lorenz R; Peck-Radosavljevic M; Veldman A; Zotz RB
    Med Klin (Munich); 2007 Jan; 102(1):70-81. PubMed ID: 17221356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy in women with congenital factor VII deficiency.
    Kulkarni AA; Lee CA; Kadir RA
    Haemophilia; 2006 Jul; 12(4):413-6. PubMed ID: 16834743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis with recombinant-activated factor VII (rFVIIa) for minimally invasive surgery in a patient with congenital factor VII deficiency: a case report with a single-low dose of rFVIIa.
    Yilmaz AA; Yalcin S; Serdaroglu H; Sonmezer M; Uysalel A
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):693-5. PubMed ID: 18832912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of factor VII-deficient patients undergoing joint surgeries--preliminary results of locally developed treatment regimen.
    Windyga J; Zbikowski P; Ambroziak P; Baran B; Kotela I; Stefanska-Windyga E
    Haemophilia; 2013 Jan; 19(1):89-93. PubMed ID: 22845882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiences with continuous infusion of recombinant activated factor VII.
    Schulman S; d'Oiron R; Martinowitz U; Pasi J; Briquel ME; Mauser-Bunschoten E; Morfini M; Ritchie B; Goudemand J; Lloyd J; McPherson J; Négrier C; Peerlinck K; Petrini P; Tusell J
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S97-101. PubMed ID: 9819037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful use of continuous infusion of FVII in urologic surgery.
    Dulícek P; Malý J; Pecka M; Rýdel L
    Haemophilia; 2008 May; 14(3):637-8. PubMed ID: 18284450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.